Revision as of 09:48, 17 March 2014 editSenator2029 (talk | contribs)Extended confirmed users29,532 edits copy edit & general fixes← Previous edit | Revision as of 03:51, 10 May 2014 edit undoCAWylie (talk | contribs)Autopatrolled, Extended confirmed users, Pending changes reviewers120,645 edits Disambiguated: Luminal → PhenobarbitalNext edit → | ||
Line 34: | Line 34: | ||
==Life and work== | ==Life and work== | ||
He was the son of the farmer Heinrich Hörlein and his wife, Philippina (née Dürk). After attending school in Alzey and Darmstadt, he began studying chemistry at the university in Darmstadt in 1900, and continued his studies in 1902 in Jena, where he received his doctoral degree in 1903. After that, he worked as an assistant to his dissertation advisor, Ludwig Knorr, until joining ]'s research laboratory at Elberfeld in 1909. There he was promoted rapidly: in 1911, he was entrusted with the supervision of the pharmaceutical laboratory, where he discovered the ] ] in 1912. He was made an authorized signatory in 1914, a deputy director in 1919, and an alternate member of Bayer’s managing board in 1921. After the formation of the conglomerate ], he was made an alternate member of the managing board here as well in 1926, as head of pharmaceutical research in Elberfeld. The same year, the University of Munich awarded him an honorary medical degree and the title Dr. med. h.c. | He was the son of the farmer Heinrich Hörlein and his wife, Philippina (née Dürk). After attending school in Alzey and Darmstadt, he began studying chemistry at the university in Darmstadt in 1900, and continued his studies in 1902 in Jena, where he received his doctoral degree in 1903. After that, he worked as an assistant to his dissertation advisor, Ludwig Knorr, until joining ]'s research laboratory at Elberfeld in 1909. There he was promoted rapidly: in 1911, he was entrusted with the supervision of the pharmaceutical laboratory, where he discovered the ] ] in 1912. He was made an authorized signatory in 1914, a deputy director in 1919, and an alternate member of Bayer’s managing board in 1921. After the formation of the conglomerate ], he was made an alternate member of the managing board here as well in 1926, as head of pharmaceutical research in Elberfeld. The same year, the University of Munich awarded him an honorary medical degree and the title Dr. med. h.c. | ||
==Footnotes== | ==Footnotes== |
Revision as of 03:51, 10 May 2014
You can help expand this article with text translated from the corresponding article in German. (April 2013) Click for important translation instructions.
|
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
Philipp Heinrich Hörlein | |
---|---|
Trial in Nurnberg | |
Born | (1882-06-05)5 June 1882 Wendelsheim, Rhenish Hesse, German Empire |
Died | 23 May 1954(1954-05-23) (aged 71) Wuppertal, Germany |
Citizenship | German |
Alma mater | Alzey University of Darmstadt |
Known for |
|
Children | Johann Sebastian Hörlein (1871-1908) |
Awards | state medal For Services to Public Health ( Error: {{Lang}}: text has italic markup (help)) (1932) |
Scientific career | |
Fields | Chemistry |
Institutions | Bayer's research, IG Farben |
Philipp Heinrich Hörlein (June 5, 1882 in Wendelsheim in Rhenish Hesse – 23 May 1954 in Wuppertal), was a German entrepreneur, scientist, lecturer, and Nazi Wehrwirtschaftsführer.
Life and work
He was the son of the farmer Heinrich Hörlein and his wife, Philippina (née Dürk). After attending school in Alzey and Darmstadt, he began studying chemistry at the university in Darmstadt in 1900, and continued his studies in 1902 in Jena, where he received his doctoral degree in 1903. After that, he worked as an assistant to his dissertation advisor, Ludwig Knorr, until joining Bayer's research laboratory at Elberfeld in 1909. There he was promoted rapidly: in 1911, he was entrusted with the supervision of the pharmaceutical laboratory, where he discovered the soporific Luminal in 1912. He was made an authorized signatory in 1914, a deputy director in 1919, and an alternate member of Bayer’s managing board in 1921. After the formation of the conglomerate I.G. Farben, he was made an alternate member of the managing board here as well in 1926, as head of pharmaceutical research in Elberfeld. The same year, the University of Munich awarded him an honorary medical degree and the title Dr. med. h.c.
Footnotes
This article about a German chemist is a stub. You can help Misplaced Pages by expanding it. |